Stay updated on AcSé: Rare Cancer Types Access Clinical Trial

Sign up to get notified when there's something new on the AcSé: Rare Cancer Types Access Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the AcSé: Rare Cancer Types Access Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The footer now displays site revision v3.8.0 instead of v3.7.2. The study page continues to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-31T21:55:00.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    A site-wide notice announces that NIH content may use “Super Intelligence” in place of “Artificial Intelligence” during a terminology transition.
    Difference
    1%
    Check dated 2026-10-24T22:25:52.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    The footer revision number changes from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-17T22:27:20.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.0 to v3.7.1 while the page continued to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-10T22:20:52.000Z thumbnail image
  5. Check
    44 days ago
    Change Detected
    Summary
    The study page for NCT03012620 now displays a 403 Forbidden error instead of the usual study details. This indicates restricted access to the trial record, blocking users from viewing core information about the trial.
    Difference
    20%
    Check dated 2026-09-19T20:52:39.000Z thumbnail image
  6. Check
    65 days ago
    Change Detected
    Summary
    Added a new funding/identifier entry (2016 ( U.S. NIH Grant/Contract )) to the study's identifiers, and updated the site revision from v3.6.5 to v3.6.6.
    Difference
    0.1%
    Check dated 2026-08-29T18:51:39.000Z thumbnail image

Stay in the know with updates to AcSé: Rare Cancer Types Access Clinical Trial

Enter your email address, and we'll notify you when there's something new on the AcSé: Rare Cancer Types Access Clinical Trial page.